| 000 | 01581 a2200433 4500 | ||
|---|---|---|---|
| 005 | 20250516180306.0 | ||
| 264 | 0 | _c20141104 | |
| 008 | 201411s 0 0 eng d | ||
| 022 | _a2212-3911 | ||
| 024 | 7 |
_a10.2174/15748863113086660063 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKobak, Senol | |
| 245 | 0 | 0 |
_aRenal cell carcinoma in a patient with rheumatoid arthritis treated with adalimumab. _h[electronic resource] |
| 260 |
_bCurrent drug safety _cMar 2014 |
||
| 300 |
_a69-72 p. _bdigital |
||
| 500 | _aPublication Type: Case Reports; Journal Article | ||
| 650 | 0 | 4 | _aAdalimumab |
| 650 | 0 | 4 |
_aAnti-Inflammatory Agents _xadverse effects |
| 650 | 0 | 4 |
_aAntibodies, Monoclonal, Humanized _xadverse effects |
| 650 | 0 | 4 |
_aAntirheumatic Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aArthritis, Rheumatoid _xcomplications |
| 650 | 0 | 4 | _aBiopsy |
| 650 | 0 | 4 |
_aCarcinoma, Renal Cell _xchemically induced |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHematuria _xetiology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHydroxychloroquine _xtherapeutic use |
| 650 | 0 | 4 |
_aKidney Neoplasms _xchemically induced |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aNephrectomy |
| 650 | 0 | 4 | _aPositron-Emission Tomography |
| 650 | 0 | 4 |
_aPrednisolone _xtherapeutic use |
| 650 | 0 | 4 | _aTomography, X-Ray Computed |
| 650 | 0 | 4 |
_aTumor Necrosis Factor-alpha _xantagonists & inhibitors |
| 700 | 1 | _aKaraarslan, Ahmet | |
| 700 | 1 | _aAktakka, Yunus | |
| 773 | 0 |
_tCurrent drug safety _gvol. 9 _gno. 1 _gp. 69-72 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.2174/15748863113086660063 _zAvailable from publisher's website |
| 999 |
_c23231239 _d23231239 |
||